Passage of Trojan peptoids into plant cells.
Efficient drug delivery is essential for many therapeutic applications. In this context, Trojan peptoids have attracted attention as powerful tools to deliver bioactive molecules into living cells. Certain cell-penetrating peptides, peptide mimetics, and peptoids have been shown to be endowed with a transport function and the structural features of this function have been characterized. However, most of the research has been done by using mammalian cell cultures as model organisms and the actual cellular mechanism of membrane passage has not been elucidated. Plant cells, which are encased in a cellulosic cell wall and differ in membrane composition, represent an alternative experimental system to address this issue, but so far, have attracted only little attention for both peptide- and peptoid-based carrier systems. Moreover, efficient delivery of nonproteinaceous bioactive macromolecules into living plant cells could complement genetic engineering in biotechnological applications, such as metabolic engineering and molecular farming. In the present study, we investigated carrier peptoids with or without guanidinium side chains with regard to their uptake into plant cells, the cellular mechanism of uptake, and intracellular localization. We can show that in contrast to polyamine peptoids (polylysine-like) fluorescently labeled polyguanidine peptoids (polyarginine-like) enter rapidly into tobacco BY-2 cells without affecting the viability of these cells. A quantitative comparison of this uptake with endocytosis of fluorescently labeled dextranes indicates that the main uptake of the guanidinium peptoids occurs between 30-60 min after the start of incubation and clearly precedes endocytosis. Dual visualization with the endosomal marker FM4-64 shows that the intracellular guanidinium peptoid is distinct from endocytotic vesicles. Once the polyguanidine peptoids have entered the cell, they associate with actin filaments and microtubules. By pharmacological manipulation of the cytoskeleton we tested whether the association with the cytoskeleton is necessary for uptake, and observed that the actin inhibitor latrunculin B as well as the microtubule inhibitor oryzalin impaired uptake and intracellular spread of the guanidinium carrier to a certain extent. These findings are discussed with respect to the potential mechanisms of uptake and with respect to the potential of Trojan peptoids as tools for metabolic engineering in plant biotechnology.
Eggenberger
Kai
K
Institute of Botany 1, University of Karlsruhe, Kaiserstrasse 2, 76128 Karlsruhe, Germany. peter.nick@bio.uni-karlsruhe.de
Birtalan
Esther
E
Schröder
Tina
T
Bräse
Stefan
S
Nick
Peter
P
D002460:Cell Line; D004337:Drug Carriers / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism*; D011992:Endosomes / Q000378:metabolism; D034444:Peptoids / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism*; D014026:Nicotiana / Q000166:cytology*
D004337:Drug Carriers; D034444:Peptoids